These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 34331461

  • 21. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N, Morton LM, Feuer EJ, Besson C, Engels EA.
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [Abstract] [Full Text] [Related]

  • 22. Statin use and breast cancer survival - a Swedish nationwide study.
    Borgquist S, Broberg P, Tojjar J, Olsson H.
    BMC Cancer; 2019 Jan 11; 19(1):54. PubMed ID: 30634941
    [Abstract] [Full Text] [Related]

  • 23. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A, Doni E, Bolis S, Rossini F, Casaroli I, Pezzatti S, Pogliani EM, Pioltelli PE.
    Clin Lymphoma Myeloma Leuk; 2015 Apr 11; 15(4):208-13. PubMed ID: 25468321
    [Abstract] [Full Text] [Related]

  • 24. Obesity and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort study.
    Leo QJ, Ollberding NJ, Wilkens LR, Kolonel LN, Henderson BE, Le Marchand L, Maskarinec G.
    Cancer Causes Control; 2014 Nov 11; 25(11):1449-59. PubMed ID: 25070667
    [Abstract] [Full Text] [Related]

  • 25. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK.
    Acta Ophthalmol; 2013 Jul 11; 91 Thesis 5():1-27. PubMed ID: 24041159
    [Abstract] [Full Text] [Related]

  • 26. Combination trial of duvelisib (IPI-145) with rituximab or bendamustine/rituximab in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia.
    Flinn IW, Cherry MA, Maris MB, Matous JV, Berdeja JG, Patel M.
    Am J Hematol; 2019 Dec 11; 94(12):1325-1334. PubMed ID: 31490009
    [Abstract] [Full Text] [Related]

  • 27. Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects.
    Smyth L, Blunt DN, Gatov E, Nagamuthu C, Croxford R, Mozessohn L, Cheung MC.
    Br J Haematol; 2020 Nov 11; 191(3):396-404. PubMed ID: 32304100
    [Abstract] [Full Text] [Related]

  • 28. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
    Hester LL, Park SI, Wood WA, Stürmer T, Brookhart MA, Lund JL.
    Cancer; 2019 Apr 01; 125(7):1101-1112. PubMed ID: 30548238
    [Abstract] [Full Text] [Related]

  • 29. Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group.
    Méndez M, Torrente M, Sánchez-Beato M, González-Rincón J, Royuela A, Gómez-Codina J, de la Cruz-Merino L, Rueda A, Llanos M, Quero C, Rodríguez-Abreu D, Gumá J, Monsalvo S, Sabin P, Provencio M.
    Hematol Oncol; 2019 Apr 01; 37(2):143-150. PubMed ID: 30840776
    [Abstract] [Full Text] [Related]

  • 30. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
    Provencio M, Royuela A, Torrente M, Pollán M, Gómez-Codina J, Sabín P, Llanos M, Gumá J, Quero C, Blasco A, Aguiar D, García-Arroyo FR, Lavernia J, Martínez N, Morales M, Saenz-Cusi Á, Rodríguez D, Calvo V, de la Cruz-Merino L, de la Cruz MÁ, Rueda A, Spanish Lymphoma Oncology Group.
    Cancer; 2017 Oct 01; 123(19):3709-3716. PubMed ID: 28608996
    [Abstract] [Full Text] [Related]

  • 31. Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data.
    Roberto G, Spini A, Bartolini C, Moscatelli V, Barchielli A, Paoletti D, Giorgi S, Fabbri A, Bocchia M, Donnini S, Gini R, Ziche M.
    PLoS One; 2020 Oct 01; 15(3):e0229973. PubMed ID: 32163477
    [Abstract] [Full Text] [Related]

  • 32. Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial.
    Howard DR, Munir T, McParland L, Rawstron AC, Chalmers A, Gregory WM, O'Dwyer JL, Smith A, Longo R, Varghese A, Smith A, Hillmen P.
    Health Technol Assess; 2017 May 01; 21(28):1-374. PubMed ID: 28628003
    [Abstract] [Full Text] [Related]

  • 33. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
    Joentausta RM, Rannikko A, Murtola TJ.
    Prostate; 2019 May 01; 79(6):583-591. PubMed ID: 30652328
    [Abstract] [Full Text] [Related]

  • 34. Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.
    Kubica AW, Rose PS, Weaver AL, Brewer JD.
    Mayo Clin Proc; 2011 Aug 01; 86(8):738-43. PubMed ID: 21803956
    [Abstract] [Full Text] [Related]

  • 35. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET, Smedby KE, Hjalgrim H, Porwit-MacDonald A, Roos G, Glimelius B, Adami HO.
    J Natl Cancer Inst; 2005 Oct 05; 97(19):1466-74. PubMed ID: 16204696
    [Abstract] [Full Text] [Related]

  • 36. Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study.
    Alexandre L, Clark AB, Bhutta HY, Chan SS, Lewis MP, Hart AR.
    Gastroenterology; 2016 Apr 05; 150(4):854-65.e1; quiz e16-7. PubMed ID: 26775632
    [Abstract] [Full Text] [Related]

  • 37. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
    Maeshima AM, Taniguchi H, Fukuhara S, Morikawa N, Munakata W, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Tobinai K, Tsuda H.
    Am J Surg Pathol; 2013 Apr 05; 37(4):563-70. PubMed ID: 23426122
    [Abstract] [Full Text] [Related]

  • 38. HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
    Bergqvist R, Ahlqvist VH, Lundberg M, Hergens MP, Sundström J, Bell M, Magnusson C.
    PLoS Med; 2021 Oct 05; 18(10):e1003820. PubMed ID: 34648516
    [Abstract] [Full Text] [Related]

  • 39. Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study.
    Livingstone E, Hollestein LM, van Herk-Sukel MP, van de Poll-Franse L, Joosse A, Schilling B, Nijsten T, Schadendorf D, de Vries E.
    Cancer Med; 2014 Oct 05; 3(5):1284-93. PubMed ID: 24935402
    [Abstract] [Full Text] [Related]

  • 40. Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study.
    Martinelli G, Montoro J, Vanazzi A, Andreola G, Liptrott S, Radice D, Negri M, Preda L, Pruneri G, Laszlo D.
    Hematol Oncol; 2015 Dec 05; 33(4):129-35. PubMed ID: 25047267
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.